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Efficacy of stem cell allograft in maxillary
sinus bone regeneration: a randomized
controlled clinical and blinded
histomorphometric study
Josh Whitt1, Mohanad Al-Sabbagh2, Dolphus Dawson1, Ehab Shehata3, Moly Housley-Smith3,
Alejandro Tezanos4 and Ahmad Kutkut5*
Abstract
Purpose: This study aimed to evaluate the quality and quantity of newly generated bone in the maxillary sinus
grafted with stem cell-based allograft material.
Methods: This study was a single site, prospective, blinded, randomized, and controlled clinical trial. Eleven subjects
with 18 edentulous posterior maxillary sites requiring sinus augmentation for delayed implant placement using a
lateral window approach were enrolled. At the time of sinus augmentation, test sinus was grafted with stem cell-
based allograft (Osteocel Plus; NuVasive Therapeutics), while the control sinus was grafted with conventional
cortico-cancellous allograft (alloOss; ACE Surgical). Cone beam computer tomography (CBCT) scan was taken before
and 14 weeks post-sinus augmentation procedure, i.e., 2 weeks before implant placement. Thirty-six trephined core
bone biopsies were harvested from the anterior and posterior grafted lateral-window osteotomy sites at the time of
implant placement.
Results: The results showed a statistically significant difference in the vital bone percentage between the test and
the control groups at the posterior grafted sites (p = 0.03). There was no significant difference in the percentage of
vital bone between the anterior and posterior grafted sites within the test and control groups (p > .05). The CBCT
analysis showed that the maxillary sinuses at the posterior grafted sites were statistically wider than those at the
anterior grafted sites in both groups (p < .05).
Conclusions: Different allograft bone materials can be used in the maxillary sinus augmentation procedures. Stem
cell allograft has more osteogenic potential with a better outcome in the wide posterior sinus.
Keywords: Maxillary sinus floor augmentation, Allograft, Stem cells, Sinus width, Dental implant
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Introduction
The maxillary sinus is pyramidal in shape, where the an-
terior part is narrower than the posterior one. Antral di-
mensions are averaged 36–45 mm in height, 25–35mm
in anterior-posterior length, and 38–45 mm in latero-
medial depth, with an average volume of 15 ml [1, 2].
Hard and soft tissue defects arise as a sequela of tooth
extraction if no ridge preservation is attempted and
maxillary sinus hyper-pneumatization poses a clinical
challenge for proper implant placement [3]. Studies re-
ported bone resorption of 0.7–1.5 mm and 4.0–4.5 mm
at vertical and horizontal alveolar bone dimensions, re-
spectively [4–6]. Most of these changes occurred during
the first 3 months of healing [5]. Posterior maxillary
tooth extraction causes inferior expansion (pneumatiza-
tion) of the sinus in relation to other fixed landmarks. A
radiographic study showed the enlarge of the sinus in an
inferior direction by 1.83 ± 2.46 mm following tooth ex-
traction. A more significant amount of expansion was
measured after second molars extraction or extractions
of two or more adjacent posterior teeth as compared to
first molars [3]. To overcome such clinical limitations,
several regenerative surgical techniques and materials
have been introduced in the literature [3–6]. Fresh au-
togenous bone, which has high osteogenic potential, is
considered the gold standard for bone regeneration in
the maxillary sinus [7]. The donor site morbidities and
low volume of available bone are the limitations of wide-
spread use. Allograft materials have been used success-
fully as scaffolding materials in clinical studies; however,
they lack cells with osteogenic potential [8].
Tissue engineering has been investigated in the aug-
mentation of the vertically deficient maxillary ridge [9].
The standard tissue engineering entails in vitro culturing
of an autologous cell onto a biological carrier (as a scaf-
fold) before in situ implantation. Several factors can
limit the in vitro cultures, such as the engineered tissue
shape and size, cell integration, cell population, and the
mechanical forces [10, 11]. A stem cell is an undifferen-
tiated cell found among differentiated cells in a tissue or
organ. It can renew itself and differentiate to a specific cell
phenotype if exposed to the proper stimuli. Growth factors
that are secreted from undifferentiated cells and have
osteoinductive properties can be directly used to repair
bone defects, which eliminate the limitations associated
with cell culture [12]. The typical growth factors used for
bone regeneration are bone morphogenic proteins (BMPs),
fibroblast growth factors (FGFs), insulin-like growth factors
I and II (IGF I/II), and platelet-derived growth factor
(PDGF). These factors lead to different cellular responses,
such as promoting cell adhesion, proliferation, migration,
and osteogenic differentiation [7, 8, 13, 14]. A combination
of growth factors and in vitro-expanded stem cells have
been employed to enhance osteogenesis. This combination
showed that stem cells could migrate effectively into and
through growth factors and increase without deforming its
cellular structure [7, 11–13].
Recent systematic reviews of human studies showed
higher bone regeneration when applying mesenchymal
stem cells compared with those with non-stem cell-
based controls [15–18]. Multiple case series using allo-
graft cellular bone matrix reported a high percentage of
vital bone content after a relatively shorter healing time
that encourages an earlier implant placement [19, 20].
Stem cell allograft has recently been available for the
use in the osseous tissue generation [21]. The stem cell
allograft, Osteocel Plus, NuVasive Therapeutics, has the
scaffold and the native undifferentiated mesenchymal
stem cells. The objective of the current study was to
evaluate the quality and quantity of newly generated
bone in the maxillary sinus grafted with stem cell-based
allograft material. Also, the histomorphometric analysis
was performed to compare the vital bone percentages in
maxillary sinuses grafted with Osteocel Plus (NuVasive/
Osiris Therapeutics, SAN DIEGO, CA) or alloOss (ACE
Surgical, Brockton, MA).
Methods
This study was a single-center, prospective, randomized,
controlled clinical, and blinded histomorphometric
study. The clinical trial was approved by the Medical In-
stitutional Review Board at the University of Kentucky,
Lexington, KY.
Randomization
Eligible patients were randomly assigned to one of two
treatment groups using a randomization table generated
by a computer. The test group (nine sinuses) received
sinus augmentation with Osteocel Plus, a stem cell allo-
graft with a scaffold, and the control group (nine sinuses)
underwent sinus augmentation with alloOss, a cortico-
cancellous particulate allograft. Patients with bilateral sites
in need of sinus augmentation had both the test and the
control groups randomized as to which sinus received
each group. Patients with single sites were randomized as
to which group was administered to that site.
Duration of study
This was a 2-year study. Follow-up examinations were at
14 days for suture removal, 14 weeks for follow-up
CBCT, and 16 weeks for implant placement and core
sample retrieval for histomorphometric analysis.
Patient selection
Seven patients with bilateral edentulous posterior maxil-
lary sites and four patients with unilateral edentulous
posterior maxillary sites requiring sinus augmentation
followed by implant placement were recruited from the
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University of Kentucky College of Dentistry and enrolled
into the study by the study investigators.
Study treatment
Screening examination (visit 1)
Nine sinuses for each group were recruited from the Uni-
versity of Kentucky College of Dentistry by the study inves-
tigators and were screened for the study. Study participants
were asked to read and sign the informed consent as well
as encouraged to ask any questions that pertained to the
study. Each patient received a copy of their informed con-
sent once signed. Medical history and dental assessments
were completed to rule out any systemic or local factors
that would compromise the outcome of the study. Intra-
oral and extra-oral soft tissue exams were performed at the
screening visit along with a preoperative CBCT to plan the
location of the lateral window sinus augmentation proced-
ure. This was considered the standard of care before any
sinus augmentation therapy.
To be included in this study, all subjects must under-
stand the research and its requirements as well as be
willing to participate, as shown by the voluntary signing
of the written informed consent. The minimum age was
at least 22-years old. Subjects also had to have at least
one posterior site requiring grafting along with an im-
plant restoration to replace one tooth in the edentulous
site. Subjects had to be in satisfactory general health
with no clinically significant positives on medical history
as well as be available for all follow-up examinations.
Subjects were excluded from the study if they couldn’t
undergo any oral surgery procedures.
Subjects were excluded if they smoked, had active
periodontal disease, dental infections of the bone, un-
controlled diabetes, if they were undergoing chemother-
apy or radiation, any autoimmune diseases, kidney or
liver disease, or if they were pregnant or breastfeeding.
Baseline surgical (visit 2) (Fig. 1)
Patients who qualified for the study and completed the
informed consent were scheduled for the sinus augmen-
tation procedure. All patients were offered to be sedated
via moderate parenteral sedation using Midazolam and
Fentanyl for the sinus augmentation procedure. After
administration of local anesthesia (2% Lidocaine with 1:
100,000 Epinephrine), a cresto-palatal incision was made
using a 15C surgical blade (Integra LifeSciences Corpor-
ation), at the posterior maxillary site requiring augmen-
tation. A full-thickness mucoperiosteal flap is reflected
with two vertical releasing incisions. The lateral window
osteotomy is created on the lateral wall of the maxillary
sinus using a #8 round diamond bur (SS White), and
Piezosurgery unit (Mectron Dental). The lateral window
was opened to reflect the Schneiderian membrane ultim-
ately (Fig. 2).
Once the Schneiderian membrane is reflected in the
medial wall of the sinus, 2 g of Osteocel Plus was applied
to the sinus of the test group, and 2 g of alloOss was used
to the control sinus, densely packing after each application
of the material. After each sinus is densely packed with
graft material, the lateral window is covered with a resorb-
able collagen membrane (conFORM resorbable collagen
membrane, ACE Surgical, Brockton, MA) to perform
guided bone regeneration and prevent the ingrowth of soft
tissue into the grafted site. Each membrane was then fixed
with two tacks: one anterior and one posterior to the lat-
eral window. All flaps were secured using interrupted su-
tures (3-0 chromic gut, Hu-Friedy Manufacturing, Co.,
LLC, Chicago, IL) with tension-free primary closure. Post-
operative instructions were given to each patient and their
escort, if sedated, after the surgical procedure.
All but one patient was prescribed augmentin 875/125
mg, one tablet every 12 h for 10 days, and was started 1
day before the surgery. The one patient allergic to Amoxi-
cillin was prescribed Zithromax 250mg (5-day PAK).
They were taking two tablets on day one, then one tablet
daily for days 2 through 5. Ibuprofen 600mg was pre-
scribed for postoperative analgesia. A total of 0.12% chlor-
hexidine gluconate was prescribed for patients to clean
the surgical area gently three times daily for 2 weeks.
Suture removal (visit 3) (Fig. 3)
Patients returned 2 weeks (14 days) after the sinus aug-
mentation procedure. At this visit, the sutures were
Fig. 1 a Pre-operative panoramic X-ray. b Pre-operative edentulous
posterior maxilla
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removed and wound healing was evaluated. Any adverse
events were documented.
Second CBCT (visit 4) (Fig. 4)
Patients were then allowed to heal for an additional 3
months (12 weeks after suture removal visit). At that
time, a second CBCT was taken to allow for the plan-
ning of the implant placements.
Core samples and implant placement (visit 5) (Figs. 5 and 6)
Patients then returned 2 weeks after the second CBCT
for the placement of the planned implants and the har-
vesting of the core samples from the lateral window site.
After local anesthesia administration, a cresto-palatal in-
cision was made, and a full-thickness flap reflected. Core
samples of 2-mm diameter were harvested with a tre-
phine bur at a speed of 1000 rpm and thorough irriga-
tion. Samples were collected from the anterior and
posterior sites of the lateral window where the bone
healing was considered least mature in a horizontal dir-
ection (lateral to medial). Tacks placed to stabilize the
resorbable membrane during the sinus augmentation
procedure were used as a reference when harvesting the
core samples. After core samples were collected, the
tacks were removed. The harvested core samples were of
such size not to compromise the ability to place the
planned implants the same day. Core samples were
placed in labeled formalin specimen tubes and taken to
Oral Pathology. The osteotomies created by the trephine
were grafted using alloOss bone graft.
Dental implants were placed through a digitally fabri-
cated surgical guide with osteotomies created according
to the implant manufacturer’s recommendations. All im-
plants placed with good primary stability based on the
torque value of at least 35 Ncm in grafted sinuses in
both groups. Cover screws were placed, and flaps se-
cured with 4-0 resorbable sutures. All patients were
given postoperative care as wells as home care instruc-
tions. Patients were also advised to clean the surgical
area gently with a Toothette Oral Swab moistened with
0.12% chlorhexidine gluconate four times daily for 2
weeks.
Study measures
The treatment was considered successful if the bone
core samples could be retrieved and enough bone was
present for implants to be placed after 4 months of heal-
ing. Failure of treatment was considered when the bone
core samples could not be harvested or implant place-
ment could not be performed at 4 months of healing.
Fig. 2 a Full-thickness flap reflected to access the lateral sinus wall. b Lateral window created. c Schneiderian membrane completely elevated to
medial expose the medial wall. d Test sinus filled with Osteocel Plus allograft material. e Collagen resorbable membrane covers the window and
stabilized with 2 tacks one anteriorly and the other one posteriorly
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Radiographic examination
A CBCT was taken as a baseline at the screening
exam before the sinus augmentation procedure as a
standard of care and at 3.5 months just before im-
plant placement also as the standard of care. The
height and width of the sinus were evaluated in the
anterior and posterior sites of the planned lateral
window. These two sagittal sections were used in
the sinus measurement analysis. On each of the sa-
gittal sections of the CBCT scan, two lines were
drawn to measure the dimension of the sinus. One
line measured the horizontal width, and the other
line measured the vertical height. The horizontal
width of the sinus was measured at a vertical height
of 10 mm from the sinus floor based on the stand-
ard average length of implants used in implant
dentistry.
Histomorphometric analysis
Thirty-six trephined core samples were retrieved surgi-
cally from the grafted lateral window at the time of im-
plant placement (visit 5). One core was retrieved from
the anterior area of the sinus, 4 mm distal to the anterior
tack, which was used for membrane fixation, and the
other sample was retrieved from the posterior region, 4
mm mesial to the posterior tack which was used for
membrane fixation.
Core samples were placed in special biopsy tubes con-
taining 10% neutral buffered formalin for fixation at least
24 h before decalcification in Decal Stat™ acid (Decal
Chemical Corporation, NY USA) for 1 h, dehydrated in
a graded series of ethanol, and embedded in Ameraffin
tissue embedding medium wax. Harvested core samples
were sent to a research laboratory (University of Ken-
tucky, Lexington, KY) for light microscopy histologic
slides preparation. The specimens were cut in the apico-
coronal plane to obtain three 6-μm-thick sections that
were used for light microscopic examination and histo-
morphometric analysis.
Photographic documentation
For each visit, photographs were taken using a digital
camera for step-by-step documentation and monitoring
of the healing process.
Adverse events
Patients were evaluated within 2 weeks for suture re-
moval and evaluation of wound healing and 14 weeks
following the sinus augmentation procedure for implant
placement and core sample retrieval. Patients were mon-
itored for any adverse reactions, i.e., complications or
failures throughout the study, and there were no adverse
events recorded related to the study protocol.
Results
All statistical analyses were completed in SAS 9.4 (SAS In-
stitute Inc., Cary, NC, USA). Significance level set at 0.05.
The results show that the test group has signifi-
cantly higher posterior vital bone than the control
group (p value 0.03) (Table 1). In the control and test
group, the anterior sinus width is significantly higher
than the posterior sinus width (p value 0.0002). The
differences between sinus width and gender were re-
ported in Table 2.
When comparing differences in sinus width by gender
using a t test, there was no evidence of statistically sig-
nificant difference (p value = 0.1435). When comparing
differences in sinus width by age using linear regression,
there was no evidence of statistically significant differ-
ence (p value = 0.7631). When comparing vital bone dif-
ferences by age using linear regression, there was no
evidence of statistically significant difference (p value =
Fig. 3 a Post-operative panoramic X-ray. b Tension-free primary
closure. c Suture removal in 2 weeks follow-up visit
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Fig. 4 a 14 weeks follow-up CBCT to plan for implant placement. b Planning implant position into the grafted sinus using coDiagnosticX
software. c Digital design for the surgical guide. d 3D-printed surgical guide
Fig. 5 a 4 months of healing before implant placement surgery. b Full-thickness flap reflection to retrieve the core samples and tacks before
implant placement. c Core samples retrieved from anterior and posterior sinus regions. d Fully guided implant placements using the surgical
guide. e Tension-free primary closure after implant surgery
Whitt et al. International Journal of Implant Dentistry            (2020) 6:25 Page 6 of 10
0.1821). When comparing vital bone differences by age
using a t test, there was evidence of statistically signifi-
cant difference (p value = 0.0071). Females have a higher
averaged vital bone difference from pre to post-op sinus
augmentation.
Additional file 1: Diagram 1 shows no significant dif-
ference in the correlation between sinus width and
gender (p value = 0.14). Additional file 2: Diagram 2
shows no significant difference in sinus width and
age using linear regression (p value = 0.76). Add-
itional file 3 Diagram 3 shows the significant differ-
ence between gender and vital bone. Females have
higher averaged vital bone difference from pre- to
post-op sinus augmentation (p value = 0.007). Add-
itional file 4: Diagram 4 shows no significant differ-
ence when comparing vital bone and age using
linear regression (p value = 0.18).
Histologic findings
Figure 7 shows the histomorphometric results with vital
bone in anterior and posterior sinus areas in both
groups.
Discussion
This investigation histomorphometrically compared
alloOss (ACE Surgical) (control group), a cortico-
cancellous allograft, to Osteocel Plus (NuVasive/Osiris
Therapeutics), an allograft cellular bone matrix (test
group) by comparing the percentage of vital bone
present at 4 months of healing. The results showed that
the test group (Osteocell) had a significantly higher vital
bone in the posterior region than the control group
(alloOss).
Tatum initially described maxillary sinus augmentation
via the lateral window techniques in the mid-seventies
[7]. The lateral window is still one of the most frequently
used treatment modalities to increase the vertical alveo-
lar bone height of the posterior maxilla before implant
rehabilitation.
Kutkut et al. [22] presented a clinical recommendation
when treatment planning maxillary sinus augmentation
based on sinus width and blood supply. The report sug-
gests that a classification technique of the maxillary
sinus anatomy based on the mean sinus width of 15.2
mm. Sinus width < 15.2 mm is proposed as a narrow
sinus cavity and classified as a quicker bone regeneration
“QBR” in terms of bone healing after sinus augmentation
procedure. On the other hand, sinus cavity wider than
15.2 mm is proposed as a wide sinus cavity and was clas-
sified as a slower bone regeneration “SBR” in terms of
bone healing.
When the width increased, the distance of the blood
supply also increased and made less blood supply avail-
able to the grafted site affecting vital bone formation.
The reasons for the correlation between height and
width may be related to the healing factors and angio-
genesis that occurs after sinus augmentation surgery
[22]. Because the blood supply to the sinus is critical for
healing and bone formation, any factor that brings this
Fig. 6 a and b Core samples retrieved from anterior and posterior
sinus regions
Table 1 The difference between test and control group on four variables: anterior sinus width and vital bone, posterior sinus width,
and vital bone
Test group (osteocell) Control group (alloOss)
Anterior sinus
width
%Vital bone Posterior sinus
width
%Vital Bone Anterior sinus
width
%Vital bone Posterior sinus
width
%Vital bone
12.35 ± 1.44mm 44.11% ± 0.33 17.27 ± 2.28mm 50.12% ± 0.35 14.15 ± 1.54mm 34.14% ± 0.35 18.49 ± 2.68mm 24.45% ± 0.23
Table 2 The difference in sinus width by gender
Gender Mean difference SD Std Err mean Lower 95% Upper 95%
Female −2.42 0.91 0.64 −10.55 5.71
Male −0.686 1.30 0.58 −2.31 0.93
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supply closer to the graft material would be expected to
improve healing [23–25]. For example, a sinus with a
narrow horizontal width, closer proximity of surround-
ing walls, would present a better source of blood supply
to the grafted bone replacement particles, which are
osteoconductive. A smaller height to width ratio would
allow cells and healing proteins less distance to migrate
during the bone regeneration process, and this was evi-
dent in the control group in this study where the vital
bone percentage was doubled in the narrow anterior
sinus compare to wide posterior sinus after 4 months of
healing [22, 26].
Regarding the blood supply to the sinus cavity, there
are three primary arteries supplying blood to the maxil-
lary sinus: the posterior superior alveolar artery, the
infraorbital artery, and the posterior lateral nasal artery.
These arteries are the branches of the maxillary artery.
The posterior lateral nasal artery supplies the medial
wall, which plays an essential role in vital bone forma-
tion. Therefore, the closer the medial wall is to the
lateral wall (narrow sinus), the better the available blood
supply to the graft material [27, 28]. Besides, this would
increase the surface area of the surrounding bone from
which new bone formation occurs. This is the reason
why the Schneiderian membrane must be elevated en-
tirely from the medial wall when performing a sinus lift
procedure. Margolin et al. [29] evaluated the perform-
ance of graft materials at different heights. They were
able to visualize on the CBCT scans that the
mineralization was more rapid near the floor of the sinus
and along the peripheral regions. This pattern of
mineralization was anticipated based on the source of
vascular ingrowth and bone-forming cells. This investi-
gation presents a classification technique, which is con-
sistent with these findings when the width and height of
the sinus are considered.
In the test group of this study, the percentage of the
vital bone of wide sinus morphology was higher than the
narrow anterior sinus. This is because of the stem cells-
based allograft Osteoinduction effect was more materials
Fig. 7 a-d Histomorphometric findings from each site and group
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existed in the wide posterior sinus. The sinus anatomy is
pyramidal in shape. The anterior part of the sinus is nar-
rower than the posterior region. Consequently, the bone
remodeling may be faster anteriorly, and therefore im-
plant placement may be more predictable in the anterior
maxilla than the posterior area.
Moreover, the success rate may be expected to be
higher in narrow or (QBR) sinus morphology. This re-
search is based on the distance of width and height of
the maxillary sinus. The actual amount of blood supply
will be determined by the exposed surface area of the
medial wall of the maxillary sinus. This study confirmed
the proposed classification [21] that correlates to the
amount of vital bone and width of the sinus and provide
evidence that the most critical factors inclusive of the
type of the graft material that may cause differences in
the amount of new vital bone formation in grafted si-
nuses is the anatomy of the maxillary sinus.
Recent systematic reviews have assessed implant sur-
vival in maxillary sinus augmentation with different
grafting materials and found that the implant survival
rate was the same regardless of the grafting material or
the time of implant placement [15–17]. Also, the reviews
have concluded that autogenous bone grafting has re-
sulted in the highest amounts of newly formed bone.
Various bone substitutes, such as xenografts, allografts,
and alloplasts, are an excellent alternative to autogenous
grafting [18]. Total bone volume after sinus augmenta-
tion revealed a significantly higher mineralized bone
during the early healing phase with autogenous grafting
compared to that of other grafting materials used alone
or in combination with autogenous grafting [19]. How-
ever, when higher than 9months of healing was
achieved, there was no statistically significant difference
between different grafting materials [18]. Conversely, it
appears that the volume of the maxillary sinus does not
influence the contraction or dimension of a particular
bone graft placed; however, in general, there seems to be
an overall decrease in graft dimensions over time [20,
21, 30]. The results of this study may be due then an in-
crease in the osteogenic potential of the test bone graft
material.
Conclusion
Sinus augmentation in the posterior maxilla can be com-
pleted with many grafting materials as well as combina-
tions of grafting materials. Sinuses augmented with
Osteocel Plus (NuVasive/Osiris Therapeutics) had a sta-
tistically significant higher vital bone percentage after
just 4 months of healing in the posterior aspect of the
sinus compared to the posterior aspect of a sinus grafted
with alloOss (ACE Surgical). More cases and monitoring
of the future survival of implants placed in these aug-
mented sinuses are needed to verify these results.
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